We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.9B
AUM Growth
-$755M
Cap. Flow
-$1.47B
Cap. Flow %
-12.34%
Top 10 Hldgs %
33.73%
Holding
1,207
New
25
Increased
513
Reduced
317
Closed
41

Top Buys

Rank Stock Value
1
WELL icon
Welltower
WELL
+$281M
2
DOC icon
Healthpeak Properties
DOC
+$233M
3
LSI
Life Storage, Inc.
LSI
+$141M
4
CONE
CyrusOne Inc Common Stock
CONE
+$139M
5
ESS icon
Essex Property Trust
ESS
+$99.1M

Top Sells

Rank Stock Value
1
BXP icon
Boston Properties
BXP
+$240M
2
HST icon
Host Hotels & Resorts
HST
+$190M
3
HR icon
Healthcare Realty
HR
+$160M
4
DLR icon
Digital Realty Trust
DLR
+$157M
5
CCI icon
Crown Castle
CCI
+$153M

Sector Composition

Rank Sector Weight
1 Real Estate 71.54%
2 Technology 3.97%
3 Industrials 3.48%
4 Financials 2.88%
5 Healthcare 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPZM
1076
DELISTED
Epizyme, Inc
EPZM
$4K ﹤0.01%
383
– –
FLXN
1077
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4K ﹤0.01%
207
– –
AMAG
1078
DELISTED
AMAG Pharmaceuticals
AMAG
$4K ﹤0.01%
195
– –
INSY
1079
DELISTED
Insys Therapeutics, Inc.
INSY
$4K ﹤0.01%
405
– –
ABUS icon
1080
Arbutus Biopharma
ABUS
$865M
$3K ﹤0.01%
304
– –
AUPH icon
1081
Aurinia Pharmaceuticals
AUPH
$1.97B
$3K ﹤0.01%
464
– –
BAC icon
1082
PUT
Bank of America
BAC
$435B
$3K ﹤0.01%
3,000
– –
COLL icon
1083
Collegium Pharmaceutical
COLL
$1.14B
$3K ﹤0.01%
180
– –
CYTK icon
1084
Cytokinetics
CYTK
$11B
$3K ﹤0.01%
298
– –
CBIO
1085
Crescent Biopharma
CBIO
$602M
$3K ﹤0.01%
2
– –
INO icon
1086
Inovio Pharmaceuticals
INO
$79.8M
$3K ﹤0.01%
42
– –
KURA icon
1087
Kura Oncology
KURA
$922M
$3K ﹤0.01%
167
– –
NERV icon
1088
Minerva Neurosciences
NERV
$188M
$3K ﹤0.01%
27
– –
NVAX icon
1089
Novavax
NVAX
$1.23B
$3K ﹤0.01%
87
– –
PACB icon
1090
Pacific Biosciences
PACB
$422M
$3K ﹤0.01%
642
– –
PRTA icon
1091
Prothena Corp
PRTA
$458M
$3K ﹤0.01%
212
– –
RIGL icon
1092
Rigel Pharmaceuticals
RIGL
$680M
$3K ﹤0.01%
81
– –
VYGR icon
1093
Voyager Therapeutics
VYGR
$187M
$3K ﹤0.01%
178
– –
PETQ
1094
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3K ﹤0.01%
73
– –
KDNY
1095
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3K ﹤0.01%
85
– –
CCXI
1096
DELISTED
ChemoCentryx, Inc.
CCXI
$3K ﹤0.01%
269
– –
ADMS
1097
DELISTED
Adamas Pharmaceuticals
ADMS
$3K ﹤0.01%
142
– –
ACHN
1098
DELISTED
Achillion Pharmaceuticals
ACHN
$3K ﹤0.01%
762
– –
DOVA
1099
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$3K ﹤0.01%
142
– –
ACRS icon
1100
Aclaris Therapeutics
ACRS
$730M
$2K ﹤0.01%
170
– –
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2018 Portfolio in Review

As of Q3 2018, Daiwa Securities Group held 1,207 positions worth $11.9B, down 5.9% from $12.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $1.47B in Q3 2018, closing 41 positions and reducing 317 holdings. Its most notable exit was SITE Centers, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 73% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Altaba Inc worth $4.33M.

  • Daiwa Securities Group's largest Q3 2018 buy was Altaba Inc: 63,550 shares worth $4.33M.
  • Daiwa Securities Group added most to Welltower in Q3 2018, an estimated $281M increase.
  • Daiwa Securities Group's biggest Q3 2018 reduction was Boston Properties, cutting an estimated $240M.
  • Daiwa Securities Group fully exited SITE Centers in Q3 2018, selling an estimated $128M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $11.9B portfolio in Q3 2018.
  • Daiwa Securities Group opened 25 new positions and closed 41 in Q3 2018.
  • Daiwa Securities Group's portfolio value fell 5.9% quarter-over-quarter to $11.9B.

Based on Daiwa Securities Group's 13F filing for Q3 2018, filed 1 Nov 2018.